PATIENT & MARKET ACCESS/ PRICING & REIMBURSEMENT

We understand the requirements for, and can undertake a fully collaborative plan involving, marketing, health economics, medical, policy, advocacy relations and communications, aligned with commercial objectives and the requirements of individual healthcare systems.

 

With our broad experience of working in a range of therapeutic areas, we are able to identify knowledge and data gaps important for the successful development of your biopharmaceutical products and  medical devices.

Our approach encompasses both the classic approach and newer paradigms

 

• Review of the therapeutic landscape

• Portfolio analysis from clinical and economic perspectives

• Trial design and generation of outcomes data

• Involvement of non-clinical decision makers

• Policy analysis and implementation national strategic targets

• Environment mapping and partnership engagement

• HTA/budget impact analysis

• Strategic Review of HEOR Planning for Market Access and Commercialization